Executive readout · one minute
What the filings say
- 10-Q report · filed Nov 12, 2026
- Fennec's nine-month PEDMARK sales rose $20,832, or 67%, to $51,697, while net income reached $6,814 versus a $4,954 loss. The Cipla settlement bars generic U.S. entry until September 1, 2033, or earlier under certain specified circumstances.
The audio replay and transcript follow the call.